Alopecia Universalis Occurring after Alemtuzumab Treatment for Multiple Sclerosis. A Two-Year Follow-Up of Two Patients

Alopecia Universalis Occurring after Alemtuzumab Treatment for Multiple Sclerosis. A Two-Year Follow-Up of Two Patients

Alopecia Universalis (AU) is the most severe form of Alopecia Areata and is caused by cytotoxic T-cells reacting with follicular autoantigens, producing complete loss of scalp and body hair. Alemtuzumab is a highly efficacious monoclonal antibody used in the treatment of Multiple Sclerosis (MS), but...

Full description

Bibliographic Details
Main Authors: Giovanna Borriello, Antonio Ianniello, Ahmed T Toosy
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:International Journal of Environmental Research and Public Health
Subjects:
multiple sclerosis
Alopecia Universalis
Alemtuzumab
clinical neurology
safety
vitamin D
Online Access:https://www.mdpi.com/1660-4601/18/14/7338

Internet

https://www.mdpi.com/1660-4601/18/14/7338

Similar Items